Effects of dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus Block: A prospective, randomized, double-blind study
Background and Aims: Various adjuvants have been added to local anesthetics in single shot blocks so as to prolong the duration of postoperative analgesia. The present study was conceived to evaluate the effect of dexmedetomidine as an adjuvant to ropivacaine for institution of supraclavicular brach...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Journal of Anaesthesiology Clinical Pharmacology |
Subjects: | |
Online Access: | http://www.joacp.org/article.asp?issn=0970-9185;year=2018;volume=34;issue=3;spage=357;epage=361;aulast=Mangal |
id |
doaj-0d02d021a8d2496a9179cf2326cafd8e |
---|---|
record_format |
Article |
spelling |
doaj-0d02d021a8d2496a9179cf2326cafd8e2020-11-25T00:42:25ZengWolters Kluwer Medknow PublicationsJournal of Anaesthesiology Clinical Pharmacology0970-91852018-01-0134335736110.4103/joacp.JOACP_182_17Effects of dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus Block: A prospective, randomized, double-blind studyVandana MangalTuhin MistryGaurav SharmaMd KazimNeelmani AhujaAmit KulshresthaBackground and Aims: Various adjuvants have been added to local anesthetics in single shot blocks so as to prolong the duration of postoperative analgesia. The present study was conceived to evaluate the effect of dexmedetomidine as an adjuvant to ropivacaine for institution of supraclavicular brachial plexus block. Material and Methods: Ninety adult patients (ASA physical status I, II) scheduled for elective upper limb surgeries under ultrasound-guided subclavian perivascular brachial plexus block were allocated randomly into two groups; the study was designed in double-blind fashion. All patients received 20 ml 0.75% ropivacaine, in addition, patients in group A (n = 43) received 2 ml 0.9% normal saline and those in group B (n = 44) received dexmedetomidine (1 μg/kg body weight); total volume was made up to 22 ml with sterile 0.9% saline in both groups. The onset and duration of sensory and motor blocks, time to first request of analgesia, total dose of postoperative analgesic administration, and level of sedation were also studied in both the groups. All the data were analyzed by using unpaired t-test. P < 0.05 was considered significant. Results: Sensory and motor block durations (613.34 ± 165.404 min and 572.7 ± 145.709 min) were longer in group B than those in group A (543.7 ± 112.089 min and 503.26 ± 123.628 min; P < 0.01). Duration of analgesia was shorter in group A (593.19 ± 114.44 min) compared to group B (704.8 ± 178.414 min; P < 0.001). Conclusion: Addition of dexmedetomidine to 0.75% ropivacaine in supraclavicular brachial plexus block significantly prolongs the duration of analgesia.http://www.joacp.org/article.asp?issn=0970-9185;year=2018;volume=34;issue=3;spage=357;epage=361;aulast=MangalDexmedetomidineropivacainesupraclavicular brachial plexus blocksubclavian perivascular blockultrasound |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vandana Mangal Tuhin Mistry Gaurav Sharma Md Kazim Neelmani Ahuja Amit Kulshrestha |
spellingShingle |
Vandana Mangal Tuhin Mistry Gaurav Sharma Md Kazim Neelmani Ahuja Amit Kulshrestha Effects of dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus Block: A prospective, randomized, double-blind study Journal of Anaesthesiology Clinical Pharmacology Dexmedetomidine ropivacaine supraclavicular brachial plexus block subclavian perivascular block ultrasound |
author_facet |
Vandana Mangal Tuhin Mistry Gaurav Sharma Md Kazim Neelmani Ahuja Amit Kulshrestha |
author_sort |
Vandana Mangal |
title |
Effects of dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus Block: A prospective, randomized, double-blind study |
title_short |
Effects of dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus Block: A prospective, randomized, double-blind study |
title_full |
Effects of dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus Block: A prospective, randomized, double-blind study |
title_fullStr |
Effects of dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus Block: A prospective, randomized, double-blind study |
title_full_unstemmed |
Effects of dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus Block: A prospective, randomized, double-blind study |
title_sort |
effects of dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus block: a prospective, randomized, double-blind study |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Anaesthesiology Clinical Pharmacology |
issn |
0970-9185 |
publishDate |
2018-01-01 |
description |
Background and Aims: Various adjuvants have been added to local anesthetics in single shot blocks so as to prolong the duration of postoperative analgesia. The present study was conceived to evaluate the effect of dexmedetomidine as an adjuvant to ropivacaine for institution of supraclavicular brachial plexus block.
Material and Methods: Ninety adult patients (ASA physical status I, II) scheduled for elective upper limb surgeries under ultrasound-guided subclavian perivascular brachial plexus block were allocated randomly into two groups; the study was designed in double-blind fashion. All patients received 20 ml 0.75% ropivacaine, in addition, patients in group A (n = 43) received 2 ml 0.9% normal saline and those in group B (n = 44) received dexmedetomidine (1 μg/kg body weight); total volume was made up to 22 ml with sterile 0.9% saline in both groups. The onset and duration of sensory and motor blocks, time to first request of analgesia, total dose of postoperative analgesic administration, and level of sedation were also studied in both the groups. All the data were analyzed by using unpaired t-test. P < 0.05 was considered significant.
Results: Sensory and motor block durations (613.34 ± 165.404 min and 572.7 ± 145.709 min) were longer in group B than those in group A (543.7 ± 112.089 min and 503.26 ± 123.628 min; P < 0.01). Duration of analgesia was shorter in group A (593.19 ± 114.44 min) compared to group B (704.8 ± 178.414 min; P < 0.001).
Conclusion: Addition of dexmedetomidine to 0.75% ropivacaine in supraclavicular brachial plexus block significantly prolongs the duration of analgesia. |
topic |
Dexmedetomidine ropivacaine supraclavicular brachial plexus block subclavian perivascular block ultrasound |
url |
http://www.joacp.org/article.asp?issn=0970-9185;year=2018;volume=34;issue=3;spage=357;epage=361;aulast=Mangal |
work_keys_str_mv |
AT vandanamangal effectsofdexmedetomidineasanadjuvanttoropivacaineinultrasoundguidedsupraclavicularbrachialplexusblockaprospectiverandomizeddoubleblindstudy AT tuhinmistry effectsofdexmedetomidineasanadjuvanttoropivacaineinultrasoundguidedsupraclavicularbrachialplexusblockaprospectiverandomizeddoubleblindstudy AT gauravsharma effectsofdexmedetomidineasanadjuvanttoropivacaineinultrasoundguidedsupraclavicularbrachialplexusblockaprospectiverandomizeddoubleblindstudy AT mdkazim effectsofdexmedetomidineasanadjuvanttoropivacaineinultrasoundguidedsupraclavicularbrachialplexusblockaprospectiverandomizeddoubleblindstudy AT neelmaniahuja effectsofdexmedetomidineasanadjuvanttoropivacaineinultrasoundguidedsupraclavicularbrachialplexusblockaprospectiverandomizeddoubleblindstudy AT amitkulshrestha effectsofdexmedetomidineasanadjuvanttoropivacaineinultrasoundguidedsupraclavicularbrachialplexusblockaprospectiverandomizeddoubleblindstudy |
_version_ |
1725282619054096384 |